The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees...

18
The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

Transcript of The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees...

Page 1: The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

The role of HDL in atherosclerosis

Prof. M. John Chapman (Paris, France)in discussion with

Dr. Kees Hovingh (Amsterdam, The Netherlands)

Page 2: The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

Genetics (1)

What is the relationship between functional mutations in the major genes

involved in HDL metabolism and cardiovascular risk?

Page 3: The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

Genetics of HDL metabolism (1)

• Studying families with carries of mutations

• Mutations in LCAT, ABCA1, ApoA-1

Page 4: The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

HDL metabolism

Page 5: The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

Genetics of HDL metabolism (2)

• Relatively small number of subjects

• Heterozygous carriers: increased IMT

• Lack of large numbers and relevance of the genes

• Different groups showing different data

• ApoA-1, one of the best targets of atherosclerosis

Page 6: The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

ApoA-1

Page 7: The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

Genetics (2)

Should we widen our studies of the key genes within a specific family or cohort?

Page 8: The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

Genetics of HDL metabolism (2)

• Individual with SRB1 mutation, but a low-normal HDL level: counterintuitive

• Sequencing ApoA-1, LCAT and ABCA1• Neutralizing effects of other monogenetic

disorders: HDL level and CAD risk• Sequencing a lot of genes all at once• Better view of the landscape of genetic disorders

underpinning HDL levels

Page 9: The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

Systems biology

Is this approach comparable with systems biology?

Page 10: The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

Systems biology (1)

• Measure enzymatic endpoints

• Concept: impact of a gene on the phenotype

• We might have been using the wrong system

Page 11: The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

Systems biology (2)

• Our field: primarily focused on murine cell lines

• Also human cell lines: little relation to the profile in in vitro cultured macrophages

Page 12: The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

HDL-mediated cholesterol efflux from cholesterol-rich macrophages

• apo E

• apo A-1

Rader DJ. J Clin Invest. 2006;116:3090–3100.

Page 13: The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

Systems biology (3)

• Effort to define standard culture conditions

• Complexity of the HDL or ApoA-1 ligand

Page 14: The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

Mechanisms of cellular cholesterol efflux to HDL particles

Page 15: The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

HDL metabolism: impact of CETP inhibition

Page 16: The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

Systems biology (4)

• CETP: most significant gene (genome studies)

• Reevaluate our ex vivo/in vitro approaches

Page 17: The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

Controversy

Is the controversy mainly associated with the systems that have been used?

Page 18: The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

Controversy

Great deal of difference between the expression of these receptors, not only in macrophages from different species, but also in human conditions